Skip to main content

Percorso to Distribute in North America for Phoenix

NEW YORK (GenomeWeb News) – Phoenix Science and Technology said today that it has tapped Percorso Life Sciences to distribute its nanospray technologies in North America.

Phoenix S&T develops injection-molded nanospray devices for use in mass spectrometry applications. Those products include the AutoNano System, a nanospray MS nozzle and nano-liquid chromatography system used for proteomics and biomarker research.

The Chester, Pa.-based company said it aims to offer more sensitivity "while consuming far less sample for use in the mass spectrometry analysis of proteins, sera, and drug-candidate molecules."

"The sales growth prospects for Phoenix's solutions are highly favorable at this time and we plan to capitalize on the market transition to micro and nanospray technology," Dino DiCamillo, president and CEO of Harleysville, Pa.-based Percorso, said in a statement.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.